Last updated on October 2017

A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer


Brief description of study

The purpose of this study is to determine whether Nivolumab in combination with other therapies is more effective than Nivolumab in combination with Ipilimumab in treating patients/subjects with advanced gastric cancer.

Clinical Study Identifier: NCT02935634

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Daniel Ahn, Site 0037

Mayo Clinic Arizona
Phoenix, AZ United States
  Connect »

Joseph Chao, Site 0020

City Of Hope National Medical Center
Duarte, CA United States
  Connect »

Stephen Leong, Site 0011

University Of Colorado
Aurora, CO United States
  Connect »

Stacey Stein, Site 0032

Yale University
New Haven, CT United States
  Connect »

Thomas George, Site 0009

UF Health Medical Oncology - Davis Cancer Pavilion
Gainesville, FL United States
  Connect »

Pashtoon Kasi, Site 0038

Mayo Clinic Jacksonville
Jacksonville, FL United States
  Connect »

Recruiting sites have contact information. ...

Moffitt Cancer Center
Tampa, FL United States
  Connect »

Christina Wu, Site 0015

Emory University
Atlanta, GA United States
  Connect »

Kelly Ronan, Site 0006

John Hopkins
Baltimore, MD United States
  Connect »

Steven Alberts, Site 0017

Mayo Clinic Rochester
Rochester, MN United States
  Connect »

Haeseong Park, Site 0003

Washington University School of Medicine
Saint Louis, MO United States
  Connect »

Martin Gutierrez, Site 0001

John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, NJ United States
  Connect »

Geoffrey Ku, Site 0007

Memorial Sloan Kettering Cancer Center
New York, NY United States
  Connect »

Rom Leidner, Site 0002

Providence Portland Medical Center
Portland, OR United States
  Connect »

Crystal Denlinger, Site 0005

Fox Chase Cancer Center
Philadelphia, PA United States
  Connect »

Nathan Bahary, Site 0010

UPMC
Pittsburgh, PA United States
  Connect »

Veena Shankaran, Site 0004

Seattle Cancer Care Assoc. Univ of Washington
Seattle, WA United States
  Connect »

Site 0035

Local Institution
Westmead, Australia
  Connect »

Site 0039

Local Institution
Heidelberg, Australia
  Connect »

Site 0034

Local Institution
Randwick, Australia
  Connect »

Site 0029

Local Institution
Edmonton, AB Canada
  Connect »

Site 0022

Local Institution
Vancouver, BC Canada
  Connect »

Site 0023

Local Institution
Halifax, NS Canada
  Connect »

Derek Jonker, Site 0024

The Ottawa Hospital Cancer Centre
Ottawa, ON Canada
  Connect »

Site 0025

Local Institution
Toronto,, ON Canada
  Connect »

Site 0021

Local Institution
Toronto, ON Canada
  Connect »

Site 0043

Local Institution
Leipzig, Germany
  Connect »

Site 0018

Local Institution
Ramat Gan, Israel
  Connect »

Site 0019

Local Institution
Tel Aviv, Israel, Israel
  Connect »

Maria Di Bartolomeo, Site 0013

IRCCS Istituto Nazionale Tumori
Milano, Italy
  Connect »

Giuseppe Curigliano, Site 0014

Istituto Europeo Di Oncologia
Milan, Italy
  Connect »

Hanneke Van Laarhoven, Site 0012

Academic Medical Center
Amsterdam, Netherlands
  Connect »

Nadia Haj Mohammad, Site 0031

Umc Utrecht
Utrecht, Netherlands
  Connect »

Site 0044

Local Institution
Badalona-barcelona, Spain
  Connect »

Site 0045

Local Institution
Madrid, Spain
  Connect »

Site 0041

Local Institution
Chur, Switzerland
  Connect »